These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 36593169)

  • 41. Genome-wide analysis of primary plasma cell leukemia identifies recurrent imbalances associated with changes in transcriptional profiles.
    Mosca L; Musto P; Todoerti K; Barbieri M; Agnelli L; Fabris S; Tuana G; Lionetti M; Bonaparte E; Sirchia SM; Grieco V; Bianchino G; D'Auria F; Statuto T; Mazzoccoli C; De Luca L; Petrucci MT; Morabito F; Offidani M; Di Raimondo F; Falcone A; Caravita T; Omedè P; Boccadoro M; Palumbo A; Neri A
    Am J Hematol; 2013 Jan; 88(1):16-23. PubMed ID: 23044976
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Nonsecretory myeloma, immunoglobulin D myeloma, and plasma cell leukemia.
    Bladé J; Kyle RA
    Hematol Oncol Clin North Am; 1999 Dec; 13(6):1259-72. PubMed ID: 10626149
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Primary Plasma Cell Leukemia: Real-World Retrospective Study of 46 Patients From a Single-Center Study in China.
    Yu T; Xu Y; An G; Tai YT; Ho M; Li Z; Deng S; Zou D; Yu Z; Hao M; Anderson KC; Qiu L
    Clin Lymphoma Myeloma Leuk; 2020 Oct; 20(10):e652-e659. PubMed ID: 32624447
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Primary plasma cell leukemia: A report of two cases of a rare and aggressive variant of plasma cell myeloma with the review of literature.
    Gangadhar P; Ahmed Z; Pai MR; Sandhya I
    Indian J Pathol Microbiol; 2016; 59(4):541-544. PubMed ID: 27721294
    [TBL] [Abstract][Full Text] [Related]  

  • 45. A Clinical Perspective on Plasma Cell Leukemia: A Single-Center Experience.
    Li AY; Kamangar F; Holtzman NG; Rapoport AP; Kocoglu MH; Atanackovic D; Badros AZ
    Cancers (Basel); 2024 Jun; 16(11):. PubMed ID: 38893268
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Clinical features and outcomes of plasma cell leukemia: a single-institution experience in the era of novel agents.
    Talamo G; Dolloff NG; Sharma K; Zhu J; Malysz J
    Rare Tumors; 2012 Jun; 4(3):e39. PubMed ID: 23087795
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Contemporaneous presentation of plasma cell leukemia and multiple myeloma. Description of a clinical case with a biclonal component].
    Pasqualetti P; Casale R; Colantonio D; Natali G
    Minerva Med; 1987 Jul; 78(13):907-10. PubMed ID: 3601136
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Plasma cell leukemia: from biology to treatment.
    Jelinek T; Kryukov F; Rihova L; Hajek R
    Eur J Haematol; 2015 Jul; 95(1):16-26. PubMed ID: 25778450
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Acquired del(9)(p22.3) in a primary plasma cell leukemia.
    Achkar WA; Wafa A; Aljapawe A; Othman MA; Alhourani E; Liehr T
    Mol Cytogenet; 2013 Aug; 6(1):33. PubMed ID: 23985162
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Clinical Features and Prognosis of Multiple Myeloma Patients with Secondary Primary Malignancies].
    Li LL; Li ML; Zhang Y; Liu Y; Liu YF; Jiang ZX; Chen SQ; Wang SJ; Wang C
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2023 Apr; 31(2):429-434. PubMed ID: 37096515
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Plasma cell leukemia in North India: retrospective analysis of a distinct clinicohematological entity from a tertiary care center and review of literature.
    Bommannan K; Sachdeva MU; Malhotra P; Kumar N; Sharma P; Naseem S; Ahluwalia J; Das R; Varma N; Prakash G; Khadwal A; Srinivasan R; Varma S
    Blood Res; 2016 Mar; 51(1):23-30. PubMed ID: 27104188
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Identification of High-Risk Multiple Myeloma With a Plasma Cell Leukemia-Like Transcriptomic Profile.
    Hofste Op Bruinink D; Kuiper R; van Duin M; Cupedo T; van der Velden VHJ; Hoogenboezem R; van der Holt B; Beverloo HB; Valent ET; Vermeulen M; Gay F; Broijl A; Avet-Loiseau H; Munshi NC; Musto P; Moreau P; Zweegman S; van de Donk NWCJ; Sonneveld P
    J Clin Oncol; 2022 Sep; 40(27):3132-3150. PubMed ID: 35357885
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Multiple myeloma and secondary plasma cell leukemia.
    Dos Santos VM; Melim SP; de Faria PS; Passini VV; Duarte ML; Casasanta RA
    Rom J Morphol Embryol; 2016; 57(2 Suppl):837-839. PubMed ID: 27833979
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Plasma cell leukemia.
    Hayman SR; Fonseca R
    Curr Treat Options Oncol; 2001 Jun; 2(3):205-16. PubMed ID: 12057120
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Pixantrone demonstrates significant in vitro activity against multiple myeloma and plasma cell leukemia.
    Willenbacher E; Jöhrer K; Willenbacher W; Flögel B; Greil R; Kircher B
    Ann Hematol; 2019 Nov; 98(11):2569-2578. PubMed ID: 31628518
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Biological and clinical relevance of miRNA expression signatures in primary plasma cell leukemia.
    Lionetti M; Musto P; Di Martino MT; Fabris S; Agnelli L; Todoerti K; Tuana G; Mosca L; Gallo Cantafio ME; Grieco V; Bianchino G; D'Auria F; Statuto T; Mazzoccoli C; De Luca L; Petrucci MT; Offidani M; Di Raimondo F; Falcone A; Caravita T; Omede' P; Morabito F; Tassone P; Boccadoro M; Palumbo A; Neri A
    Clin Cancer Res; 2013 Jun; 19(12):3130-42. PubMed ID: 23613318
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Plasma Cell Leukemia: Definition, Presentation, and Treatment.
    Gundesen MT; Lund T; Moeller HEH; Abildgaard N
    Curr Oncol Rep; 2019 Jan; 21(1):8. PubMed ID: 30689121
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Primary plasma cell leukemia and autologous stem cell transplantation.
    Drake MB; Iacobelli S; van Biezen A; Morris C; Apperley JF; Niederwieser D; Björkstrand B; Gahrton G;
    Haematologica; 2010 May; 95(5):804-9. PubMed ID: 20442444
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Clinical outcomes of patients with plasma cell leukemia in the era of novel therapies and hematopoietic stem cell transplantation strategies: a single-institution experience.
    Lebovic D; Zhang L; Alsina M; Nishihori T; Shain KH; Sullivan D; Ochoa-Bayona JL; Kharfan-Dabaja MA; Baz R
    Clin Lymphoma Myeloma Leuk; 2011 Dec; 11(6):507-11. PubMed ID: 21813352
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [The clinical characteristics of patients with primary plasma cell leukemia and the efficacy of novel agents and hematopoietic stem cell transplantation].
    Li WJ; Wang FR; Wen L; Chen Y; Chen H; Huang XJ; Lu J
    Zhonghua Nei Ke Za Zhi; 2020 Oct; 59(10):801-806. PubMed ID: 32987483
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.